Kalaris Therapeutics Inc (KLRS) Annual Balance Sheets

Annual · GAAP · USD millions
Access KLRS quarterly Balance Sheets →
This balance sheet overview for Kalaris Therapeutics Inc spans from Dec 31 2021 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent98.05
Short-term Investments, Total19.93
Cash & Short-term Investments117.00
Notes Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.83
Total Current Assets118.81
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent2.93
Prepaid Expenses To Related Party-
Restricted Cash Noncurrent0.50
Restricted Cash-
Operating Lease Right Of Use Asset1.48
Total Assets121.74
Liabilities
Accounts Payable, Current AC1.28
Workers Compensation Liability, Current0.00
Other Liabilities, Current8.43
Taxes Payable0.00
Total Current Liabilities9.71
Total Long-term Debt0.00
Other liabilities, Noncurrent33.21
RoyaltyObligationDueToRelatedPartyNoncurrent32.08
Accrued Research And Development Expenses Current-
Accrued Expenses And Other Current Liabilities8.12
Total Liabilities42.92
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock238.81
Retained Earnings / Accumulated Deficit-160.00
Other Equity0.01
Common Stockholder's Equity78.81
Total Stockholder's Equity78.81
Liabilities & Stockholder's Equity121.74
4 historic quarters locked

Sign in to unlock the full Kalaris Therapeutics Inc balance sheet history.

About Kalaris Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-110659

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License